CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Income (Loss) from Continuing Operations, Per Diluted Share
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) reported Income (Loss) from Continuing Operations, Per Diluted Share of $7.20 per share for the 12-month period ending 2020-12-26, per its 10-K filed 2021-02-17.
Discontinued › Expense Statement › Operating Expenses
us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare · last filed 2021-02-17
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. income (loss) from continuing operations, per diluted share for the quarter ending 2019-12-28 was $1.61, a 33.06% increase year-over-year.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. income (loss) from continuing operations, per diluted share for the quarter ending 2019-09-28 was $1.46, a 19.67% increase year-over-year.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. income (loss) from continuing operations, per diluted share for the quarter ending 2019-06-29 was $0.88, a 16.98% decline year-over-year.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. income (loss) from continuing operations, per diluted share for the quarter ending 2019-03-30 was $1.11, a 2.78% increase year-over-year.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. income (loss) from continuing operations, per diluted share for fiscal 2020 was $7.20, a 42.01% increase from fiscal 2019.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. income (loss) from continuing operations, per diluted share for fiscal 2019 was $5.07, a 10.46% increase from fiscal 2018.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. income (loss) from continuing operations, per diluted share for fiscal 2018 was $4.59, a 80.71% increase from fiscal 2017.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. income (loss) from continuing operations, per diluted share for fiscal 2017 was $2.54, a 21.12% decline from fiscal 2016.
| Period end | Income (Loss) from Continuing Operations, Per Diluted Share 3 month | Income (Loss) from Continuing Operations, Per Diluted Share 3 month as first filed | Income (Loss) from Continuing Operations, Per Diluted Share 6 month | Income (Loss) from Continuing Operations, Per Diluted Share 9 month | Income (Loss) from Continuing Operations, Per Diluted Share 9 month as first filed | Income (Loss) from Continuing Operations, Per Diluted Share 12 month |
|---|---|---|---|---|---|---|
| 2020-12-26 | $7.20 10-K · filed 2021-02-17 | |||||
| 2019-12-28 | $1.61 10-K · filed 2020-02-11 | $5.07 10-K · filed 2021-02-17 | ||||
| 2019-09-28 | $1.46 10-K · filed 2020-02-11 | $3.46 10-Q · filed 2019-11-06 | ||||
| 2019-06-29 | $0.88 10-K · filed 2020-02-11 | $1.99 10-Q · filed 2019-07-31 | ||||
| 2019-03-30 | $1.11 10-K · filed 2020-02-11 | |||||
| 2018-12-29 | $1.21 10-K · filed 2020-02-11 | $4.59 10-K · filed 2021-02-17 | ||||
| 2018-09-29 | $1.22 10-K · filed 2020-02-11 | $3.36 10-Q · filed 2019-11-06 | ||||
| 2018-06-30 | $1.06 10-K · filed 2020-02-11 | $2.14 10-Q · filed 2019-07-31 | ||||
| 2018-03-31 | $1.08 10-K · filed 2020-02-11 | |||||
| 2017-12-30 | -$0.63 10-K · filed 2019-02-13 | $2.54 10-K · filed 2020-02-11 | ||||
| 2017-09-30 | $1.09 10-K · filed 2019-02-13 | $3.17 10-Q · filed 2018-11-07 | ||||
| 2017-07-01 | $1.12 10-K · filed 2019-02-13 | $2.08 10-Q · filed 2018-08-08 | ||||
| 2017-04-01 | $0.97 10-K · filed 2019-02-13 | |||||
| 2016-12-31 | $0.93 10-K · filed 2018-02-13 | $3.22 10-K · filed 2019-02-13 | ||||
| 2016-09-24 | $0.78 10-K · filed 2018-02-13 | $2.29 10-Q · filed 2017-11-09 | ||||
| 2016-06-25 | $0.73 10-K · filed 2018-02-13 | $1.51 10-Q · filed 2017-08-09 | ||||
| 2016-03-26 | $0.78 10-K · filed 2018-02-13 | |||||
| 2015-12-26 | $0.69 10-K · filed 2017-02-14 | $3.15 10-K · filed 2018-02-13 | ||||
| 2015-09-26 | $0.79 10-K · filed 2017-02-14 | $2.47 10-Q · filed 2016-11-02 | ||||
| 2015-06-27 | $1.02 10-K · filed 2017-02-14 | $1.68 10-Q · filed 2016-08-03 | ||||
| 2015-03-28 | $0.66 10-K · filed 2017-02-14 | |||||
| 2014-12-27 | $0.59 10-K · filed 2016-02-12 | $2.70 10-K · filed 2017-02-14 | ||||
| 2014-09-27 | $0.68 10-K · filed 2016-02-12 | $2.11 10-Q · filed 2015-11-04 | ||||
| 2014-06-28 | $0.75 10-K · filed 2016-02-12 | $1.43 10-Q · filed 2015-07-30 | ||||
| 2014-03-29 | $0.67 10-K · filed 2016-02-12 | |||||
| 2013-12-28 | $0.40 10-K · filed 2015-02-17 | $2.15 10-K · filed 2016-02-12 | ||||
| 2013-09-28 | $0.64 10-K · filed 2015-02-17 | $1.75 10-Q · filed 2014-10-30 | ||||
| 2013-06-29 | $0.58 10-K · filed 2015-02-17 | $1.11 10-Q · filed 2014-08-07 | ||||
| 2013-03-30 | $0.53 10-K · filed 2015-02-17 | |||||
| 2012-12-29 | $2.10 10-K · filed 2015-02-17 | |||||
| 2012-09-29 | $0.46 10-Q · filed 2013-10-30 | $1.63 10-Q · filed 2013-10-30 | ||||
| 2012-06-30 | $0.63 10-Q · filed 2013-07-31 | $1.17 10-Q · filed 2013-07-31 | ||||
| 2012-03-31 | $0.54 10-Q · filed 2013-05-08 | |||||
| 2011-12-31 | $2.24 10-K · filed 2014-02-25 | |||||
| 2011-09-24 | $0.37 10-Q · filed 2012-11-01 | $1.69 10-Q · filed 2012-11-01 | ||||
| 2011-06-25 | $0.66 10-Q · filed 2012-08-07 | $1.30 10-Q · filed 2012-08-07 | ||||
| 2011-03-26 | $0.65 10-Q · filed 2012-05-04 | |||||
| 2010-12-25 | -$5.25 10-K · filed 2013-02-27 | |||||
| 2010-09-25 | -$0.38 10-Q · filed 2011-11-02 | -$0.40 10-Q · filed 2010-11-04 | $0.14 10-Q · filed 2011-11-02 | $0.11 10-Q · filed 2010-11-04 | ||
| 2010-06-26 | $0.24 10-Q · filed 2011-08-03 | $0.50 10-Q · filed 2011-08-03 | ||||
| 2010-03-27 | $0.27 10-Q · filed 2011-05-04 | |||||
| 2009-12-26 | $1.72 10-K · filed 2012-02-27 | |||||
| 2009-09-26 | $0.52 10-Q · filed 2010-11-04 | $1.42 10-Q · filed 2010-11-04 | ||||
| 2008-12-27 | -$7.85 10-K · filed 2011-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |